Millendo therapeutics, inc. (MLND)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Dec'11
Assets
Current assets:
Cash and cash equivalents

58,007

62,478

47,151

55,274

65,587

73,286

31,917

24,601

19,721

17,578

24,775

22,937

25,433

43,930

50,480

95,894

20,478

43,224

50,842

70,238

134,698

6,414

12,125

16,553

56,134

18,078

21,077

28,193

43,188

14,776

35,119

34,067

4,541

Short-term investments

-

-

-

-

-

-

14,433

29,027

38,577

-

50,961

63,622

73,669

70,458

80,515

51,759

89,610

83,438

90,830

85,381

34,641

53,817

60,041

64,815

33,331

26,349

28,489

26,152

16,515

16,615

-

-

-

Short-term restricted cash

870

1,034

703

699

45

45

789

-

-

45

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

-

-

1,400

4,385

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

4,211

6,344

4,483

6,416

4,174

3,373

1,847

547

835

1,084

1,871

2,535

2,048

2,056

2,459

2,458

2,542

3,002

3,541

3,434

1,886

1,647

1,448

1,247

605

650

841

917

481

574

460

209

44

Refundable tax credit

1,536

1,276

1,315

2,123

1,530

2,333

-

-

-

1,031

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

197

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Short-term restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

109

-

109

109

109

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

64,624

71,132

53,652

64,512

72,736

83,422

48,986

54,175

59,133

19,738

77,607

89,094

101,150

116,444

133,454

150,111

112,739

129,861

145,322

159,162

171,334

61,878

73,614

82,615

90,070

45,077

50,407

55,262

60,184

31,965

35,579

34,276

4,585

Property and equipment, net

-

-

-

-

-

-

108

403

2,935

-

3,606

3,956

4,707

5,572

8,047

8,149

8,667

8,313

6,717

4,208

4,159

3,367

3,103

1,909

1,202

880

730

890

895

756

654

434

-

Investment in joint venture

-

-

-

-

-

-

140

142

146

-

0

0

0

65

435

-

215

0

241

557

196

-

585

1,108

1,403

1,500

-

-

-

-

-

-

-

Long-term restricted cash

-

-

494

658

439

439

0

789

-

-

-

-

-

439

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use assets

2,900

3,331

3,568

2,349

797

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term restricted cash

-

-

-

-

-

-

-

-

791

-

789

812

439

-

439

439

439

439

527

527

88

197

197

197

88

88

-

-

-

93

-

-

-

Other assets

555

507

765

805

333

213

0

24

24

74

23

23

23

23

23

23

-

0

0

0

-

130

-

-

-

-

88

88

88

-

93

275

-

Total assets

68,045

74,970

58,479

68,324

74,305

84,074

49,234

55,533

63,029

19,812

82,025

93,885

106,319

122,543

142,398

158,722

122,060

138,613

152,807

164,454

175,777

65,572

77,499

85,829

92,763

47,545

51,225

56,240

61,167

32,814

36,326

34,985

4,585

Liabilities and stockholders’ equity
Current liabilities:
Current portion of debt

258

208

197

-

-

189

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of debt

-

-

-

199

191

-

-

-

-

174

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

2,773

1,495

2,691

3,091

2,344

1,998

604

757

1,024

1,298

2,691

3,275

2,384

2,183

2,770

2,466

4,218

3,352

4,156

2,987

2,493

2,520

2,983

1,408

1,943

1,654

791

216

948

875

1,069

605

276

Accrued expenses

6,738

9,066

5,776

6,147

5,746

7,630

-

-

-

2,619

-

-

-

-

-

-

-

7,891

-

-

-

7,654

5,820

5,646

4,344

4,120

1,365

1,596

1,146

1,211

845

1,205

399

Operating lease liabilities — current

1,442

1,751

1,849

1,492

1,004

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other current liabilities

-

-

-

-

-

-

3,277

3,990

4,008

-

6,212

8,544

8,207

-

8,496

8,274

7,589

-

5,707

4,611

4,116

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

11,211

12,520

10,513

10,929

9,285

9,817

3,881

4,747

5,032

4,091

8,903

11,819

10,591

13,209

11,266

10,740

11,807

11,243

9,863

7,598

6,609

10,174

8,803

7,054

6,287

5,774

2,156

1,812

2,094

2,086

1,914

1,810

675

Debt, net of current portion

110

168

218

278

325

383

-

-

-

599

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

2,078

2,395

2,690

1,865

817

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock warrant liability

-

-

-

-

-

-

-

-

-

139

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

7

16

229

227

192

752

442

576

664

-

834

925

1,006

1,116

-

-

-

520

358

149

74

73

71

78

74

70

65

15

11

7

-

-

87

Deferred rent and other non-current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,255

1,425

1,409

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

13,406

15,099

13,650

13,299

10,619

10,952

4,323

5,323

5,696

4,829

9,737

12,744

11,597

14,325

12,521

12,165

13,216

11,763

10,221

7,747

6,683

10,247

8,874

7,132

6,361

5,844

2,221

1,827

2,105

2,093

1,914

1,810

762

Commitments and contingencies (Note 6)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

0

0

0

0

0

Stockholders’ equity:
Redeemable noncontrolling interests

-

-

-

-

-

-

-

-

-

10,584

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stockholders’ equity
Preferred stock, $0.001 par value: 5,000,000 shares authorized; no shares issued and outstanding

0

0

-

-

-

0

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.001 par value: 100,000,000 shares authorized; 18,998,252 and 18,266,545 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

19

18

13

13

13

13

36

36

36

-

36

36

36

36

36

36

27

27

27

27

27

24

24

24

23

18

17

17

18

13

14

3

2

Additional paid-in capital

274,340

267,018

238,893

237,136

235,815

234,876

367,110

366,735

366,178

6,192

365,226

364,739

360,145

358,419

357,397

354,755

298,499

294,910

289,947

286,168

280,972

150,025

144,433

141,566

139,374

86,851

83,162

81,709

80,334

46,848

46,340

804

245

Accumulated deficit

-220,700

-208,654

-195,955

-184,323

-174,452

-164,086

-322,232

-316,552

-308,850

-136,894

-292,953

-283,585

-265,400

-250,177

-227,534

-208,243

-189,675

-167,917

-147,316

-129,394

-111,904

-94,698

-75,808

-62,885

-52,992

-45,178

-34,178

-27,287

-21,291

-16,134

-11,942

-8,824

-2,624

Accumulated other comprehensive income

123

165

123

140

139

148

-3

-9

-31

8

-21

-49

-59

-60

-22

9

-7

-170

-72

-94

-1

-26

-24

-8

-3

10

3

-26

1

-6

-

-

-

Total stockholders’ equity attributable to Millendo Therapeutics, Inc.

53,830

58,547

43,074

52,966

61,515

70,951

44,911

50,210

57,333

-130,694

72,288

81,141

94,722

108,218

129,877

146,557

108,844

126,850

142,586

156,707

169,094

55,325

68,625

78,697

86,402

41,701

49,004

54,413

59,062

30,721

34,412

-8,017

-2,377

Equity attributable to noncontrolling interests

809

1,324

1,755

2,059

2,171

2,171

-

-

-

2,171

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders’ equity

54,639

59,871

44,829

55,025

63,686

73,122

-

-

-

-128,523

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities and stockholders’ equity

68,045

74,970

58,479

68,324

74,305

84,074

49,234

55,533

63,029

19,812

82,025

93,885

106,319

122,543

142,398

158,722

122,060

138,613

152,807

164,454

175,777

65,572

77,499

85,829

92,763

47,545

51,225

56,240

61,167

32,814

36,326

34,985

4,585

Convertible preferred stock
Convertible preferred stock

-

-

-

-

-

-

-

-

-

132,922

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series A preferred stock
Convertible preferred stock

-

-

-

-

-

-

-

-

-

15,220

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series A-1 preferred stock
Convertible preferred stock

-

-

-

-

-

-

-

-

-

7,566

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B preferred stock
Convertible preferred stock

-

-

-

-

-

-

-

-

-

71,778

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B-1 preferred stock
Convertible preferred stock

-

-

-

-

-

-

-

-

-

38,358

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-